Ambra Da Ros

Padova, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting.

Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting.

Journal: Blood advances
Published: August 06, 2025

Leukemic Cells Hijack Stromal Bioelectricity to Reprogram the Bone Marrow Niche via CaV1.2-Dependent Mechanisms.

Leukemic Cells Hijack Stromal Bioelectricity to Reprogram the Bone Marrow Niche via CaV1.2-Dependent Mechanisms.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2025

CD84 is a specific target for acute myeloid leukemia CAR-T cell therapy.

CD84 is a specific target for acute myeloid leukemia CAR-T cell therapy.

Journal: Nature communications
Published: April 12, 2025

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group.

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group.

Journal: Biomedicines
Published: May 20, 2022

Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.

Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.

Journal: Frontiers in pharmacology
Published: November 22, 2021

The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics.

The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics.

Journal: iScience
Published: July 01, 2021

NPM1 Mutational Status Underlines Different Biological Features in Pediatric AML.

NPM1 Mutational Status Underlines Different Biological Features in Pediatric AML.

Journal: Cancers
Published: June 16, 2021

Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.

Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.

Journal: Blood
Published: November 06, 2020

Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.

Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.

Journal: Blood advances
Published: April 06, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026